- Details
- Description
Packaging Size:
30 tablets
Strength:
150 mg
Composition:
Tucatinib
Treatment:
Anti-Cancer / Oncology
Form:
Tablet
Brand:
Tukanic 150
Quantity Unit:
Tablets
Manufacturer:
Ziska Pharmaceuticals Limited
Tukanic 150 (Tucatinib) is an oral targeted anti-cancer medicine containing tucatinib, a selective HER2 tyrosine kinase inhibitor that blocks HER2 signaling involved in the growth and spread of cancer cells. It is used in combination with other anticancer medicines for the treatment of HER2-positive breast cancer, including unresectable locally advanced or metastatic disease and certain patients with brain metastases. Tukanic 150 contains 150 mg of tucatinib and is supplied as tablets.
